It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The transient receptor potential channel TRPM7 is a master regulator of the organismal balance of divalent cations that plays an essential role in embryonic development, immune responses, cell mobility, proliferation, and differentiation. TRPM7 is implicated in neuronal and cardiovascular disorders, tumor progression and has emerged as a new drug target. Here we use cryo-EM, functional analysis, and molecular dynamics simulations to uncover two distinct structural mechanisms of TRPM7 activation by a gain-of-function mutation and by the agonist naltriben, which show different conformational dynamics and domain involvement. We identify a binding site for highly potent and selective inhibitors and show that they act by stabilizing the TRPM7 closed state. The discovered structural mechanisms provide foundations for understanding the molecular basis of TRPM7 channelopathies and drug development.
Authors present the structural mechanisms of TRPM7 spontaneous and agonist-induced opening and inhibition by potent and selective antagonists.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Correia, Leonor 2 ; Narangoda, Chamali 3
; Patel, Dhilon S. 3 ; Neuberger, Arthur 1
; Gudermann, Thomas 4
; Kurnikova, Maria G. 3
; Chubanov, Vladimir 2
; Sobolevsky, Alexander I. 1
1 Columbia University, Department of Biochemistry and Molecular Biophysics, New York, USA (GRID:grid.21729.3f) (ISNI:0000000419368729)
2 Walther-Straub Institute of Pharmacology and Toxicology, LMU Munich, Munich, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X)
3 Carnegie Mellon University, Chemistry Department, Pittsburgh, USA (GRID:grid.147455.6) (ISNI:0000 0001 2097 0344)
4 Walther-Straub Institute of Pharmacology and Toxicology, LMU Munich, Munich, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X); Comprehensive Pneumology Center, German Center for Lung Research (DZL), Munich, Germany (GRID:grid.452624.3)




